Remicade get approval in Europe for UC

Centocor's Remicade has received EU approval for the treatment of ulcerative colitis, a chronic inflammatory disease. This is the eighth approved use for Remicade in the EU and the first biologic therapy approved to treat UC in the European Union.

- see this press release

ALSO: GlaxoSmithKline has submitted its vaccine Cervarix to European regulators for approval. Their submission comes only months behind Merck's Gardasil, which was presented for approval late last year. Both vaccines aim to treat cervical cancer and will compete for market share if they are approved. Article